|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0120 EUR | +1.69% |
|
-1.64% | -90.06% |
| 16/04 | Futures lack momentum; focus remains on Middle East | AN |
| 15/04 | European markets mixed as Lovaglio retains control of MPS | AN |
| Capitalization | 17.98L 21.19L 16.48L 15.65L 28.93L 20Cr 29.55L 1.93Cr 76.06L 9.51Cr 79.49L 77.85L 34Cr | P/E ratio 2023 |
-4.71x | P/E ratio 2024 | -0.14x |
|---|---|---|---|---|---|
| Enterprise value | 73.45L 86.56L 67.33L 63.94L 1.18Cr 81Cr 1.21Cr 7.9Cr 3.11Cr 39Cr 3.25Cr 3.18Cr 137.26Cr | EV / Sales 2023 |
0.5x | EV / Sales 2024 | 0.44x |
| Free-Float |
57.88% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +1.69% | ||
| 1 week | -1.64% | ||
| Current month | -29.41% | ||
| 1 month | -40.00% | ||
| 3 months | -90.10% | ||
| 6 months | -94.77% | ||
| Current year | -90.06% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.03 | |
| Current year | 0.01 | 0.13 | |
| 1 year | 0.01 | 0.74 | |
| 3 years | 0.01 | 147 | |
| 5 years | 0.01 | 284 | |
| 10 years | 0.01 | 1,075 |
| Manager | Title | Age | Since |
|---|---|---|---|
Secondo Dentis
DFI | Director of Finance/CFO | 80 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Morgagni
BRD | Director/Board Member | 52 | 14/07/2017 |
Luigi Maniglio
CHM | Chairman | 64 | 01/01/2021 |
Roberto Culicchi
BRD | Director/Board Member | 61 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.69% | -1.64% | -97.55% | -99.99% | 2L | ||
| -2.09% | -6.26% | +113.00% | +547.95% | 2.11TCr | ||
| +0.42% | +1.79% | +56.56% | +29.43% | 1.58TCr | ||
| +1.25% | +6.56% | +191.97% | +51.64% | 1.37TCr | ||
| +3.43% | +12.13% | +242.22% | +36.73% | 975.75Cr | ||
| +0.61% | -0.59% | +96.41% | +190.65% | 598.64Cr | ||
| -0.51% | +0.24% | +9.74% | -6.05% | 555.8Cr | ||
| +0.38% | +6.00% | +10.29% | +15.04% | 484.73Cr | ||
| +1.13% | +0.75% | +21.40% | +3.65% | 434.54Cr | ||
| +3.24% | -3.09% | +59.94% | +284.38% | 423.77Cr | ||
| Average | +0.96% | +0.89% | +70.40% | +105.34% | 852.72Cr | |
| Weighted average by Cap. | +0.40% | +1.40% | +108.95% | +181.55% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.87Cr 3.39Cr 2.63Cr 2.5Cr 4.62Cr 314.93Cr 4.72Cr 31Cr 12Cr 151.94Cr 13Cr 12Cr 536.96Cr | 1.75Cr 2.07Cr 1.61Cr 1.53Cr 2.82Cr 192.17Cr 2.88Cr 19Cr 7.42Cr 93Cr 7.75Cr 7.59Cr 327.65Cr |
| Net income | -13.07L -15.4L -11.98L -11.38L -21.02L -14Cr -21.47L -1.41Cr -55.27L -6.91Cr -57.77L -56.57L -24Cr | -92.98L -1.1Cr -85.22L -80.93L -1.5Cr -101.9Cr -1.53Cr -10Cr -3.93Cr -49Cr -4.11Cr -4.02Cr -173.75Cr |
| Net Debt | 82.74L 97.5L 75.84L 72.02L 1.33Cr 91Cr 1.36Cr 8.9Cr 3.5Cr 44Cr 3.66Cr 3.58Cr 154.61Cr | 55.47L 65.37L 50.84L 48.28L 89.23L 61Cr 91.13L 5.96Cr 2.35Cr 29Cr 2.45Cr 2.4Cr 103.65Cr |
Employees
140
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 0.0120 € | +1.69% | 8,93,410 |
| 20/26/20 | 0.0118 € | +3.51% | 79,68,769 |
| 17/26/17 | 0.0114 € | -5.00% | 68,23,373 |
| 16/26/16 | 0.0120 € | +1.69% | 77,76,464 |
| 15/26/15 | 0.0118 € | -3.28% | 1,11,17,650 |
- Stock Market
- Equities
- FDA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















